P&K Skin Research Center Co., Ltd. (KOSDAQ:347740)
South Korea · Delayed Price · Currency is KRW 1,914.00
-12.00 (-0.62%)
At close: Jun 4, 2026
P&K Skin Research Center Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Revenue | 22,561 | 22,783 | 17,847 | 14,843 | 17,957 |
Other Revenue | - | -0 | -0 | - | - |
| 22,561 | 22,783 | 17,847 | 14,843 | 17,957 | |
Revenue Growth (YoY) | 12.13% | 27.66% | 20.24% | -17.34% | - |
Cost of Revenue | 12,313 | 12,113 | 9,409 | 7,668 | 6,865 |
Gross Profit | 10,249 | 10,670 | 8,438 | 7,175 | 11,092 |
Selling, General & Admin | 5,055 | 4,611 | 3,828 | 3,918 | 3,428 |
Research & Development | 1,640 | 1,624 | 1,519 | 1,357 | 1,670 |
Other Operating Expenses | 73.44 | 24.65 | 23.15 | 29.3 | 19.82 |
Operating Expenses | 7,261 | 6,730 | 5,856 | 5,796 | 5,452 |
Operating Income | 2,988 | 3,940 | 2,582 | 1,379 | 5,640 |
Interest Expense | -52.29 | -52.29 | -26.49 | -32.77 | -25.77 |
Interest & Investment Income | 2,997 | 2,997 | 3,753 | 3,808 | 2,215 |
Currency Exchange Gain (Loss) | -3.67 | -3.67 | 0.86 | -0.29 | 0.03 |
Other Non Operating Income (Expenses) | -523.69 | -375.76 | -224.19 | 63.36 | 546.89 |
EBT Excluding Unusual Items | 5,405 | 6,505 | 6,085 | 5,217 | 8,377 |
Gain (Loss) on Sale of Investments | -760.03 | -760.03 | 712.69 | 140.01 | -185.18 |
Gain (Loss) on Sale of Assets | 4.53 | 5.58 | -0.31 | -0 | -0.97 |
Pretax Income | 4,649 | 5,751 | 6,797 | 5,357 | 8,190 |
Income Tax Expense | 912.51 | 1,147 | 1,097 | 656.54 | 1,060 |
Earnings From Continuing Operations | 3,737 | 4,604 | 5,701 | 4,700 | 7,130 |
Minority Interest in Earnings | 79.86 | 81.77 | 115.58 | 112.75 | - |
Net Income | 3,816 | 4,685 | 5,816 | 4,813 | 7,130 |
Net Income to Common | 3,816 | 4,685 | 5,816 | 4,813 | 7,130 |
Net Income Growth | -44.35% | -19.45% | 20.84% | -32.50% | - |
Shares Outstanding (Basic) | 29 | 29 | 29 | 30 | 30 |
Shares Outstanding (Diluted) | 29 | 29 | 29 | 30 | 30 |
Shares Change (YoY) | 0.49% | -0.53% | -3.19% | 0.58% | - |
EPS (Basic) | 131.66 | 162.22 | 200.32 | 160.48 | 239.12 |
EPS (Diluted) | 131.66 | 162.22 | 200.32 | 160.48 | 239.12 |
EPS Growth | -44.63% | -19.02% | 24.83% | -32.89% | - |
Free Cash Flow | 4,550 | 5,177 | 8,410 | 4,023 | 6,277 |
Free Cash Flow Per Share | 156.95 | 179.25 | 289.65 | 134.13 | 210.50 |
Dividend Per Share | 50.000 | 50.000 | 40.000 | 30.000 | 35.000 |
Dividend Growth | 25.00% | 25.00% | 33.33% | -14.29% | - |
Gross Margin | 45.43% | 46.84% | 47.28% | 48.34% | 61.77% |
Operating Margin | 13.24% | 17.29% | 14.47% | 9.29% | 31.41% |
Profit Margin | 16.92% | 20.57% | 32.59% | 32.43% | 39.71% |
Free Cash Flow Margin | 20.17% | 22.72% | 47.12% | 27.10% | 34.96% |
EBITDA | 5,058 | 5,994 | 4,431 | 3,114 | 7,108 |
EBITDA Margin | 22.42% | 26.31% | 24.83% | 20.98% | 39.59% |
D&A For EBITDA | 2,071 | 2,054 | 1,848 | 1,735 | 1,468 |
EBIT | 2,988 | 3,940 | 2,582 | 1,379 | 5,640 |
EBIT Margin | 13.24% | 17.29% | 14.47% | 9.29% | 31.41% |
Effective Tax Rate | 19.63% | 19.95% | 16.13% | 12.26% | 12.95% |
Advertising Expenses | - | 150.94 | 92.33 | 123.34 | 312.82 |